Search research articles
Contact Us
Filters
Showing results (61-70 of 69) with videos related to
Page
of 7
Sort By:
You have reached the last page of results.
This site can display upto 69 results.
Cell Stem Cell
|
October 4, 2020
Human Pluripotent Stem Cell-Derived Neural Cells and Brain Organoids Reveal SARS-CoV-2 Neurotropism Predominates in Choroid Plexus Epithelium
Fadi Jacob, Sarshan R Pather, Wei-Kai Huang, et al.
Signal Transduction and Targeted Therapy
|
November 25, 2025
Anti-CD38 monoclonal antibody CM313 for systemic lupus erythematosus: a randomized, double-blind, placebo-controlled phase Ib/IIa trial
Jiuliang Zhao, Changsong Lin, Qibing Xie, et al.
Scientific Data
|
February 7, 2025
A Comprehensive Dataset on Microbiome Dynamics in Rheumatoid Arthritis from a Large-Scale Cohort Study
Jing Li, Jun Xu, Jiayang Jin, et al.
Cell
|
March 5, 2019
Quiescence Modulates Stem Cell Maintenance and Regenerative Capacity in the Aging Brain
Georgios Kalamakis, Daniel Brüne, Srikanth Ravichandran, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
May 26, 2026
Rapid subunit-level multi-attribute monitoring of succinimide and other PTMs for enhanced quality control of therapeutics antibodies
Jin Xu, Chenjing Xu, Gang Wu, et al.
Nature Communications
|
April 21, 2026
Low dose IL-2 therapy restores regulatory T cells in patients with systemic lupus erythematosus in a dose-dependent manner: a phase IIb trial
Xia Zhang, Ruiling Feng, Yifan Wang, et al.
BMC Medicine
|
December 8, 2025
Efficacy and safety of Janus kinase 1/2 inhibitor KL130008 in active rheumatoid arthritis: a randomized, double-blind, placebo-controlled phase II trial
Yue Cheng, Honghu Tang, Yufeng Qing, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
November 17, 2025
Xeligekimab, an Interleukin-17A Antagonist for Active Radiographic Axial Spondyloarthritis in Chinese Patients: 16- and 48-Week Results from a Phase III, Randomized, Double-Blind, Placebo-Controlled Study
Shangzhu Zhang, Dong Xu, Shengyun Liu, et al.
Lupus Science & Medicine
|
November 9, 2022
Comparison of short interval and low dose (SILD) with high dose of cyclophosphamide in the susceptibility to infection in SLE: a multicentrereal-world study
Miao Shao, Miao Miao, Xia Zhang, et al.
Page
of 7
Search research articles
Search
Showing results (61-70 of 69) with videos related to
Sort By:
Page
of 7
You have reached the last page of results.
This site can display upto 69 results.
Cell Stem Cell
|
October 4, 2020
Human Pluripotent Stem Cell-Derived Neural Cells and Brain Organoids Reveal SARS-CoV-2 Neurotropism Predominates in Choroid Plexus Epithelium
Fadi Jacob, Sarshan R Pather, Wei-Kai Huang, et al.
Signal Transduction and Targeted Therapy
|
November 25, 2025
Anti-CD38 monoclonal antibody CM313 for systemic lupus erythematosus: a randomized, double-blind, placebo-controlled phase Ib/IIa trial
Jiuliang Zhao, Changsong Lin, Qibing Xie, et al.
Scientific Data
|
February 7, 2025
A Comprehensive Dataset on Microbiome Dynamics in Rheumatoid Arthritis from a Large-Scale Cohort Study
Jing Li, Jun Xu, Jiayang Jin, et al.
Cell
|
March 5, 2019
Quiescence Modulates Stem Cell Maintenance and Regenerative Capacity in the Aging Brain
Georgios Kalamakis, Daniel Brüne, Srikanth Ravichandran, et al.
Journal of Pharmaceutical and Biomedical Analysis
|
May 26, 2026
Rapid subunit-level multi-attribute monitoring of succinimide and other PTMs for enhanced quality control of therapeutics antibodies
Jin Xu, Chenjing Xu, Gang Wu, et al.
Nature Communications
|
April 21, 2026
Low dose IL-2 therapy restores regulatory T cells in patients with systemic lupus erythematosus in a dose-dependent manner: a phase IIb trial
Xia Zhang, Ruiling Feng, Yifan Wang, et al.
BMC Medicine
|
December 8, 2025
Efficacy and safety of Janus kinase 1/2 inhibitor KL130008 in active rheumatoid arthritis: a randomized, double-blind, placebo-controlled phase II trial
Yue Cheng, Honghu Tang, Yufeng Qing, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
|
November 17, 2025
Xeligekimab, an Interleukin-17A Antagonist for Active Radiographic Axial Spondyloarthritis in Chinese Patients: 16- and 48-Week Results from a Phase III, Randomized, Double-Blind, Placebo-Controlled Study
Shangzhu Zhang, Dong Xu, Shengyun Liu, et al.
Lupus Science & Medicine
|
November 9, 2022
Comparison of short interval and low dose (SILD) with high dose of cyclophosphamide in the susceptibility to infection in SLE: a multicentrereal-world study
Miao Shao, Miao Miao, Xia Zhang, et al.
Page
of 7